fda approved tirzepatide approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price New weight-loss treatment becomes first

The results of a new study raises serious concerns about the risk of vision side effects from Ozempic and Wegovy, indicating that certain users of the blockbuster diabetes and weight loss drugs could experience a condition known as non-arteritic anterior ischemic optic neuropathy (NAION), which can result in sudden vision changes, and potentially lead to blindness

Semaglutide can affect your central nervous system because it can cross the blood-brain barrier to affect areas of the brain involved in appetite regulation and nausea perception, potentially contributing to nausea and even vomiting

Save $200 compared to the monthly plan

By delaying gastric emptying, tirzepatide ensures that both nutrients and medications remain in the stomach for an extended period